Ever-advancing chronic myeloid leukemia treatment

Author： Kimura Shinya   Ando Toshihiko   Kojima Kensuke  

Publisher： Springer Publishing Company

ISSN： 1341-9625

Source： International Journal of Clinical Oncology, Vol.19, Iss.1, 2014-02, pp. : 3-9

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Chronic myeloid leukemia following the treatment of rectal adenocarcinoma

By Kadikoylu Gurhan   Yavasoglu Irfan   Barutca Sabri   Meydan Nezih   Bolaman Zahit  

Medical Oncology, Vol. 25, Iss. 4, 2008-12 ,pp. : 467-470

Humana Press, Inc

Access to resources Recommend Favorite

Tyrosine Kinase Inhibitors for the Treatment of Chronic Myeloid Leukemia

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 9, Iss. 8, 2009-10 ,pp. : 853-863

Bentham Science Publishers

Access to resources Recommend Favorite

Decitabine for the treatment of atypical chronic myeloid leukemia: A report of two cases

By          

Oncology Letters, Vol. 11, Iss. 1, 2016-01 ,pp. : 689-692

Spandidos Publications

Access to resources Recommend Favorite

Imatinib and chronic myeloid leukemia: close to the bone

By Terpos Evangelos  

Leukemia and Lymphoma, Vol. 54, Iss. 8, 2013-08 ,pp. : 1581-1582

Informa Healthcare

Access to resources Recommend Favorite

Chronic Myeloid Leukemia: The Value of Tyrosine Kinase Inhibition

By Tariq I. Mughal   John M. Goldman  

American Journal of Cancer, Vol. 2, Iss. 5, 2003-01 ,pp. : 305-311

Adis International

Access to resources Recommend Favorite